Browsing Neurocentre Magendie - U1215 by Institution "CNRS"
Now showing items 1-20 of 55
-
Place des biomarqueurs dans la renutrition des patients ayant une infection grave à Covid-19 : discussion autour d’un cas clinique
(Annales de Biologie Clinique. vol. 80, n° 1, pp. 15-27, 2022-02)Article de revue -
Striatopallidal cannabinoid type-1 receptors mediate amphetamine-induced sensitization
(2023-10)Document de travail - Pré-publicationOpen access -
Vangl2 in the Dentate Network Modulates Pattern Separation and Pattern Completion
(Cell Reports. vol. 31, n° 10, pp. 107743, 2020-06-09)Article de revueOpen access -
Early Administration of the Phytocannabinoid Cannabidivarin Prevents the Neurobehavioral Abnormalities Associated with the Fmr1-KO Mouse Model of Fragile X Syndrome
(Cells. vol. 12, n° 15, pp. 1927, 2023-07-25)Article de revueOpen access -
Does food use disorder exist? Item response theory analyses of a food use disorder adapted from the DSM-5 substance use disorder criteria in a treatment seeking clinical sample
(Drug and Alcohol Dependence. vol. 251, 2023-10-01)Article de revue -
Camkiiβ in neuronal development and plasticity: An emerging candidate in brain diseases
(International Journal of Molecular Sciences. vol. 21, n° 19, pp. 1-15, 2020-10-01)Article de revueOpen access -
Effect of cognitive rehabilitation on neuropsychological and semiecological testing and on daily cognitive functioning in multiple sclerosis: The REACTIV randomized controlled study
(2020-08-15)Document de travail - Pré-publicationOpen access -
Structural progression of Alzheimer's disease over decades: The MRI staging scheme
(Brain Communications. vol. 4, n° 3, 2022-04-28)Article de revueOpen access -
Natalizumab Treatment Induces Proinflammatory CD4 T Cells Preferentially in the Integrin β7+ Compartment
(Neurology(R) neuroimmunology & neuroinflammation. vol. 10, n° 6, 2023-09-22)Article de revueOpen access -
Lifespan neurodegeneration of the human brain in multiple sclerosis
(Human Brain Mapping. vol. 44, n° 17, pp. 5602-5611, 2023-03-14)Article de revueOpen access -
Hippocampal-amygdalo-ventricular atrophy score: Alzheimer disease detection using normative and pathological lifespan models.
(Human Brain Mapping. vol. 43, n° 10, pp. 3270-3282, 2022-07)Article de revueOpen access -
High B-value diffusion tensor imaging for early detection of hippocampal microstructural alteration in a mouse model of multiple sclerosis
(Scientific Reports. vol. 12, n° 1, pp. 12008, 2022-07-14)Article de revueOpen access -
The role of the endocannabinoid system as a therapeutic target for autism spectrum disorder: Lessons from behavioral studies on mouse models
(Neuroscience and Biobehavioral Reviews. vol. 132, pp. 664-678, 2022-01)Article de revueOpen access -
Normal-Appearing White Matter Integrity Is a Predictor of Outcome after Ischemic Stroke
(Stroke. vol. 51, n° 2, pp. 449-456, 2020-02)Article de revueOpen access -
Resective epilepsy surgery and its impact on depression in adults: a systematic review, meta-analysis, and implications for future research
(Journal of Neurology, Neurosurgery and Psychiatry, 2024-03-05)Article de revue -
GRK2‐ Targeted Knockdown as Therapy for Multiple System Atrophy
(Movement Disorders. vol. 38, n° 7, pp. 1336-1340, 2023-07)Article de revueOpen access -
Rituximab De-escalation in Patients With Neuromyelitis Optica Spectrum Disorder
(Neurology. vol. 101, n° 4, pp. E438-E450, 2023-07-25)Article de revue -
Acute cannabinoids impair working memory through astroglial CB1 receptor modulation of hippocampal LTD.
(Cell. vol. 148, n° 5, pp. 1039-50, 2012-03-02)Article de revueOpen access -
Differential vulnerability of thalamic nuclei in multiple sclerosis
(Multiple Sclerosis Journal, 2022-08-12)Article de revueOpen access -
DeepLesionBrain: Towards a broader deep-learning generalization for multiple sclerosis lesion segmentation
(2022-06-13)Document de travail - Pré-publicationOpen access